YU7901A - Nova primena derivata taksoida - Google Patents

Nova primena derivata taksoida

Info

Publication number
YU7901A
YU7901A YU7901A YUP7901A YU7901A YU 7901 A YU7901 A YU 7901A YU 7901 A YU7901 A YU 7901A YU P7901 A YUP7901 A YU P7901A YU 7901 A YU7901 A YU 7901A
Authority
YU
Yugoslavia
Prior art keywords
new use
taxoid
taxoid derivatives
derivatives
relates
Prior art date
Application number
YU7901A
Other languages
English (en)
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115401A external-priority patent/EP0982027A1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU7901A publication Critical patent/YU7901A/sh
Publication of RS52011B publication Critical patent/RS52011B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Ovaj pronalazak se odnosi na novu primenu derivata taksoida. Preciznije, on se odnosi na dobivanje leka za lečenje abnormalne proliferacije ćelija u mozgu sisara uključujući čoveka.[The present invention relates to a new use of taxoid derivatives. It relates more precisely to a method for treating abnormal cell proliferation in the brain of mammals including men by administrating a taxoid derivative.
YU7901A 1998-08-17 1999-08-13 Nova primena derivata taksoida RS52011B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115401A EP0982027A1 (en) 1998-08-17 1998-08-17 Taxoid derivatives for treating abnormal cell proliferation of the brain
US9958198P 1998-09-08 1998-09-08
PCT/EP1999/006291 WO2000009120A1 (en) 1998-08-17 1999-08-13 New use of taxoid derivatives

Publications (2)

Publication Number Publication Date
YU7901A true YU7901A (sh) 2003-12-31
RS52011B RS52011B (sr) 2012-04-30

Family

ID=26149540

Country Status (19)

Country Link
US (1) US6346543B1 (sh)
EP (1) EP1109547A1 (sh)
JP (1) JP5354762B2 (sh)
KR (1) KR100710533B1 (sh)
AU (1) AU766168B2 (sh)
BG (1) BG65365B1 (sh)
CA (1) CA2340921C (sh)
CZ (1) CZ293959B6 (sh)
EE (1) EE04903B1 (sh)
HU (1) HU230235B1 (sh)
ID (1) ID27545A (sh)
IL (1) IL141238A0 (sh)
ME (1) ME00533B (sh)
NO (1) NO327296B1 (sh)
NZ (1) NZ509965A (sh)
RS (1) RS52011B (sh)
SK (1) SK285212B6 (sh)
TR (1) TR200100557T2 (sh)
WO (1) WO2000009120A1 (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
EP2206720A1 (en) * 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
AU2002364587A1 (en) * 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
EP2261250B1 (en) * 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
CN102770131A (zh) 2009-10-29 2012-11-07 安万特医药股份有限公司 卡巴他赛的新颖抗肿瘤用途
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
SG11201404712UA (en) * 2012-02-10 2014-09-26 Aventis Pharma Sa New pediatric uses of cabazitaxel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
AU766168B2 (en) 2003-10-09
CZ2001604A3 (en) 2001-06-13
HUP0103748A3 (en) 2003-01-28
SK2302001A3 (en) 2001-09-11
ID27545A (id) 2001-04-12
CZ293959B6 (cs) 2004-08-18
NZ509965A (en) 2003-09-26
CA2340921A1 (en) 2000-02-24
WO2000009120A8 (en) 2001-04-05
JP2002522490A (ja) 2002-07-23
ME00533B (me) 2011-10-10
KR100710533B1 (ko) 2007-04-23
SK285212B6 (sk) 2006-09-07
HU230235B1 (hu) 2015-10-28
EP1109547A1 (en) 2001-06-27
BG65365B1 (bg) 2008-04-30
IL141238A0 (en) 2002-03-10
WO2000009120A1 (en) 2000-02-24
TR200100557T2 (tr) 2001-07-23
NO20010654L (no) 2001-02-07
EE04903B1 (et) 2007-10-15
HUP0103748A2 (hu) 2002-04-29
RS52011B (sr) 2012-04-30
US6346543B1 (en) 2002-02-12
EE200100079A (et) 2002-08-15
KR20010085396A (ko) 2001-09-07
JP5354762B2 (ja) 2013-11-27
NO327296B1 (no) 2009-06-02
AU5741999A (en) 2000-03-06
BG105264A (en) 2001-11-30
NO20010654D0 (no) 2001-02-07
CA2340921C (en) 2009-01-06

Similar Documents

Publication Publication Date Title
YU7901A (sh) Nova primena derivata taksoida
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
MY117248A (en) Benzopyran-containing compounds and method for their use
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
BR0114054A (pt) Método para tratar alergias usando pirazóis substituìdos
GR3035774T3 (en) Substituted benzolactam compounds as substance p antagonists
TW200407305A (en) Novel compounds
AP2002002596A0 (en) Piperazine and piperidine derivatives.
DE69531682D1 (de) Sterolderivate für die regulierung der meiose
SG129448A1 (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
NZ523446A (en) (Aminoalkylbenzoyl) benzofuran or benzothiophene, their process of prepation and the compositions comprising them
MXPA01003501A (es) Metodo para moderar el estres o tension de las plantas.
MXPA03001536A (es) (aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
MY107354A (en) Substituted cyclohexenes as central nervous system agents
PL331321A1 (en) Treatment pf psychotic disorders
PL346113A1 (en) New use of taxoid derivatives
RO118794B1 (ro) Metodă de tratament a unor stări dependente de steroizii gonadici
IL139303A0 (en) Treatment of arthritis and other similar conditions
AU1930801A (en) Indole derivatives for the treatment of depression and anxiety
IL136225A0 (en) Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
AP2000001958A0 (en) Paroxetine 10-camphorsulfornate for treatment of CNS disorders.